Drug
Deleobuvir sodium clinical trials
Also written BI 207127 NA.
A product of Deleobuvir; its studies count on that page too.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
7 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Faldaprevir sodium (2) · Faldaprevir (2) · Ribavirin (1) · Midazolam (1) · Tolbutamide (1)
Studies
Open first, then newest update. How each study uses deleobuvir sodium is read from its arms, and is right about nine times in ten.
Testing it · 7
- Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected PatientsCompletedPhase 1Boehringer IngelheimNCT02176525Written as BI 207127 NA
- Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian VolunteersCompletedPhase 1Boehringer IngelheimNCT01347086Written as BI 207127 NA (medium dose)
- This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis CCompletedPhase 2Boehringer IngelheimNCT01528735Written as BI 207127 NA
- Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT01605461Written as BI 207127 NA
- Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02182414Written as BI 207127 NA (TF-I)
- Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02182388Written as BI 207127 NA tablet
- Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male VolunteersTerminatedPhase 1Boehringer IngelheimNCT02182401Written as BI 207127 NA
Codes
What other systems call deleobuvir sodium · ClinicalTrials.gg INT015337
- UNII (FDA) 6X4T3L6431DELEOBUVIR SODIUMConfirmed FDA, Wikidata
- Wikidata Q27265655deleobuvir sodiumConfirmed FDA, Wikidata
- NCI Thesaurus C166966Deleobuvir SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6X4T3L6431 | DELEOBUVIR SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27265655 | deleobuvir sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166966 | Deleobuvir Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.